Cargando…

Cerebral hemodynamics and endothelial function in patients with Fabry disease

BACKGROUND: Cerebral vasculopathy have been described in Fabry disease, in which altered cerebral blood flow, vascular remodelling or impairment of endothelial function could be involved. Our study aims to evaluate these three possibilities in a group of Fabry patients, and compare it to healthy con...

Descripción completa

Detalles Bibliográficos
Autores principales: Segura, Tomás, Ayo-Martín, Oscar, Gómez-Fernandez, Isabel, Andrés, Carolina, Barba, Miguel A, Vivancos, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828577/
https://www.ncbi.nlm.nih.gov/pubmed/24207059
http://dx.doi.org/10.1186/1471-2377-13-170
_version_ 1782291263664422912
author Segura, Tomás
Ayo-Martín, Oscar
Gómez-Fernandez, Isabel
Andrés, Carolina
Barba, Miguel A
Vivancos, José
author_facet Segura, Tomás
Ayo-Martín, Oscar
Gómez-Fernandez, Isabel
Andrés, Carolina
Barba, Miguel A
Vivancos, José
author_sort Segura, Tomás
collection PubMed
description BACKGROUND: Cerebral vasculopathy have been described in Fabry disease, in which altered cerebral blood flow, vascular remodelling or impairment of endothelial function could be involved. Our study aims to evaluate these three possibilities in a group of Fabry patients, and compare it to healthy controls. METHODS: Cerebral hemodynamics, vascular remodelling and systemic endothelial function were investigated in 10 Fabry patients and compared to data from 17 healthy controls. Transcranial Doppler was used to study blood flow velocity of intracranial arteries and cerebral vasomotor reactivity. For the study of vascular remodelling and endothelial function, intima-media thickness of common carotid arteries, flow-mediated dilation in brachial artery and serum levels of soluble VCAM-1, TNF-α, high-sensitive CRP and IL-6 were measured. Differences between groups were evaluated using appropriate tests. RESULTS: No relevant differences were observed in cerebral hemodynamic parameters, intima-media thickness or flow-mediated dilation. There was a trend for low serum levels of IL-6 and high serum levels of TNF-α and high-sensitive CRP in Fabry patients; plasma concentrations of soluble VCAM-1 were significantly higher in Fabry disease patients than in healthy volunteers (p = 0.02). CONCLUSIONS: In our sample, we did not find relevant alterations of cerebral hemodynamics in Fabry disease patients. Increased levels of plasmatic endothelial biomarkers seem to be the most important feature indicative of possible vascular dysfunction in Fabry disease patients.
format Online
Article
Text
id pubmed-3828577
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38285772013-11-16 Cerebral hemodynamics and endothelial function in patients with Fabry disease Segura, Tomás Ayo-Martín, Oscar Gómez-Fernandez, Isabel Andrés, Carolina Barba, Miguel A Vivancos, José BMC Neurol Research Article BACKGROUND: Cerebral vasculopathy have been described in Fabry disease, in which altered cerebral blood flow, vascular remodelling or impairment of endothelial function could be involved. Our study aims to evaluate these three possibilities in a group of Fabry patients, and compare it to healthy controls. METHODS: Cerebral hemodynamics, vascular remodelling and systemic endothelial function were investigated in 10 Fabry patients and compared to data from 17 healthy controls. Transcranial Doppler was used to study blood flow velocity of intracranial arteries and cerebral vasomotor reactivity. For the study of vascular remodelling and endothelial function, intima-media thickness of common carotid arteries, flow-mediated dilation in brachial artery and serum levels of soluble VCAM-1, TNF-α, high-sensitive CRP and IL-6 were measured. Differences between groups were evaluated using appropriate tests. RESULTS: No relevant differences were observed in cerebral hemodynamic parameters, intima-media thickness or flow-mediated dilation. There was a trend for low serum levels of IL-6 and high serum levels of TNF-α and high-sensitive CRP in Fabry patients; plasma concentrations of soluble VCAM-1 were significantly higher in Fabry disease patients than in healthy volunteers (p = 0.02). CONCLUSIONS: In our sample, we did not find relevant alterations of cerebral hemodynamics in Fabry disease patients. Increased levels of plasmatic endothelial biomarkers seem to be the most important feature indicative of possible vascular dysfunction in Fabry disease patients. BioMed Central 2013-11-11 /pmc/articles/PMC3828577/ /pubmed/24207059 http://dx.doi.org/10.1186/1471-2377-13-170 Text en Copyright © 2013 Segura et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Segura, Tomás
Ayo-Martín, Oscar
Gómez-Fernandez, Isabel
Andrés, Carolina
Barba, Miguel A
Vivancos, José
Cerebral hemodynamics and endothelial function in patients with Fabry disease
title Cerebral hemodynamics and endothelial function in patients with Fabry disease
title_full Cerebral hemodynamics and endothelial function in patients with Fabry disease
title_fullStr Cerebral hemodynamics and endothelial function in patients with Fabry disease
title_full_unstemmed Cerebral hemodynamics and endothelial function in patients with Fabry disease
title_short Cerebral hemodynamics and endothelial function in patients with Fabry disease
title_sort cerebral hemodynamics and endothelial function in patients with fabry disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828577/
https://www.ncbi.nlm.nih.gov/pubmed/24207059
http://dx.doi.org/10.1186/1471-2377-13-170
work_keys_str_mv AT seguratomas cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease
AT ayomartinoscar cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease
AT gomezfernandezisabel cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease
AT andrescarolina cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease
AT barbamiguela cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease
AT vivancosjose cerebralhemodynamicsandendothelialfunctioninpatientswithfabrydisease